nomifensine has been researched along with Migraine Disorders in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murialdo, G | 1 |
| Martignoni, E | 1 |
| De Maria, A | 1 |
| Bonura, ML | 1 |
| Sances, G | 1 |
| Bono, G | 1 |
| Polleri, A | 1 |
1 other study available for nomifensine and Migraine Disorders
| Article | Year |
|---|---|
Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine.
Topics: Adult; Domperidone; Dopamine; Estradiol; Female; Follicular Phase; Humans; Lisuride; Luteal Phase; M | 1986 |